Literature DB >> 1168172

Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus.

J Hurd, R B Heath.   

Abstract

Induced immunosuppression with the drug cyclophosphamide was shown to convert the relatively harmless infection with an avirulent strain of Kunz influenza virus into a fatal pneumonic illness. The drug was also shown to increase the mortality of mice infected with low concentrations of a virulent variant of this strain, but it delayed the time of death of mice that were infected with high concentrations ofthe same variant. The probable roles of immune and inflammatory mechanisms in recovery from primary influenza virus infections are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168172      PMCID: PMC415152          DOI: 10.1128/iai.11.5.886-889.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  SPARING EFFECT OF X-RAYS FOR MICE INOCULATED INTRANASALLY WITH EGG-ADAPTED INFLUENZA VIRUS, CAM STRAIN.

Authors:  B S BERLIN
Journal:  Proc Soc Exp Biol Med       Date:  1964-12

2.  The effect of cyclophosphamide on Sendai virus infection of mice.

Authors:  T W Robinson; R J Cureton; R B Heath
Journal:  J Med Microbiol       Date:  1969-05       Impact factor: 2.472

3.  The pathogenesis of Sendai virus infection in the mouse lung.

Authors:  T W Robinson; R J Cureton; R B Heath
Journal:  J Med Microbiol       Date:  1968-08       Impact factor: 2.472

Review 4.  Effects of anti-lymphoid sera on viral infections.

Authors:  M S Hirsch; F A Murphy
Journal:  Lancet       Date:  1968-07-06       Impact factor: 79.321

5.  Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide.

Authors:  G A Cole; N Nathanson
Journal:  Nature       Date:  1968-10-26       Impact factor: 49.962

6.  Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis.

Authors:  S H Singer; M Ford; R L Kirschstein
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

7.  Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.

Authors:  S H Singer; P Noguchi; R L Kirschstein
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

  7 in total
  24 in total

Review 1.  Viruses as anticancer drugs.

Authors:  Stephen J Russell; Kah-Whye Peng
Journal:  Trends Pharmacol Sci       Date:  2007-06-18       Impact factor: 14.819

2.  Cell-mediated immunity to Sendai virus infection in mice.

Authors:  M J Anderson; D R Bainbridge; J R Pattison; R B Heath
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

4.  The role of humoral immunity in host defence against influenza A infection in mice.

Authors:  J L Virelizier; J S Oxford; G C Schild
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

5.  Modulation of delayed-type hypersensitivity and cellular immunity to microbial vaccines: effects of cyclophosphamide on the immune response to tularemia vaccine.

Authors:  M S Ascher; D Parker; J L Turk
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

6.  Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.

Authors:  Mitsutaka Kitano; Makoto Kodama; Yasushi Itoh; Takushi Kanazu; Masanori Kobayashi; Ryu Yoshida; Akihiko Sato
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

7.  Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.

Authors:  S Tsuru; K Nomoto; M Taniguchi; H Fujisawa; Y Zinnaka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Antibody production and protection against influenza virus in immunodeficient mice.

Authors:  S J Lucas; D W Barry; P Kind
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 9.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

10.  Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona.

Authors:  B Adler; S Faine
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.